P25. Access to diagnostics: a bottleneck for immunotherapeutics development - case example of MAGE-A3 cancer immunotherapeutic

Lykopoulos, K; Collins, P; Hall, M; Ehness, R; Barth, J; Louahed, J

doi:10.1186/2051-1426-2-S2-P16

Article metrics
Last updated: Fri, 19 Apr 2024 18:34:09 Z

P25. Access to diagnostics: a bottleneck for immunotherapeutics development - case example of MAGE-A3 cancer immunotherapeutic

Access & Citations

841

Article Accesses
0

Web of Science
0

CrossRef

Citation counts are provided from Web of Science and CrossRef. The counts may vary by service, and are reliant on the availability of their data. Counts will update daily once available.